CaMK

Autocamtide-3 is a selective substrate for Ca2+/calmodulin-dependent kinase II (CaMKII), characterized by its 13-amino-acid sequence that includes the phosphorylatable residue Thr287. This peptide serves as a valuable tool for studying the activation and regulation of CaMKII in various biological contexts. Its application in research encompasses investigations into calcium signaling, neuronal function, and cardiac physiology.

HOCPCA is a selective inhibitor of CaMKIIα, a key regulator of calcium-dependent signaling pathways. This compound exhibits neuroprotective properties, enhancing sensorimotor functions and promoting hippocampal neuronal activity following experimental stroke in murine models. It effectively modulates abnormal CaMKII signaling, normalizes Thr286 autophosphorylation post-ischemia, and downregulates specific active CaMKII fragments associated with ischemic conditions. Additionally, HOCPCA demonstrates superior binding affinity to the GHB site, alongside excellent blood-brain barrier permeability, making it a valuable tool for research into neuroprotection and cognitive function.

CaMKII-IN-3 is a potent inhibitor of Calcium/Calmodulin-dependent protein kinase II (CaMKII), demonstrating an IC50 of less than 10 nM. This compound is valuable in research focused on the role of CaMKII in cardiac function and related heart diseases. Its application may provide insights into disease mechanisms and potential therapeutic strategies.

Protein kinase inhibitor 8 (Compound CK59) is a selective inhibitor of calmodulin-dependent protein kinase II (CaMKII). This compound effectively reduces cytotoxicity induced by perfluorooctane sulfonic acid (PFOS) and mitigates the downregulation of GLT-1 expression, leading to decreased neuronal damage. Protein kinase inhibitor 8 is a valuable tool for research into neurodegenerative diseases and the molecular mechanisms underlying neuronal stress responses.

Calmodulin Dependent Protein Kinase Substrate Analog is a synthetic peptide designed as a substrate for calmodulin-dependent protein kinases (CaMK). As a Ca2+- and calmodulin-dependent substrate, it facilitates the study of CaMK activity and regulation in cellular signaling pathways. This analog is valuable for investigating phosphorylation processes and the role of CaMK in various biological systems, making it a useful tool in biochemical and pharmacological research.

CaMKIIα-PHOTAC is a photochemically targeted chimera designed to selectively degrade Ca2+/calmodulin-dependent protein kinase II α (CaMKIIα). Upon exposure to specific wavelengths of light, this compound facilitates the ubiquitination and subsequent degradation of CaMKIIα through the endogenous proteasome pathway. Its application has demonstrated a reduction in synaptic function, notably diminishing the amplitude of evoked field excitatory postsynaptic potentials in the mouse hippocampus, thereby implicating its role in the modulation of long-term potentiation and memory processes in dendritic regions.